Alignment Healthcare, Inc.
$21.56
▲
5.1%
2026-04-21 05:13:00
www.alignmenthealth.com
NMS: ALHC
Explore Alignment Healthcare, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.34 B
Current Price
$21.56
52W High / Low
$23.87 / $11.62
Stock P/E
—
Book Value
$0.88
Dividend Yield
—
ROCE
2.9%
ROE
-0.7%
Face Value
—
EPS
$0
Exp Qtr EPS
—
Sector
Healthcare
Industry
Healthcare Plans
Employees
1,849
Beta
1.2
Debt / Equity
184.97
Current Ratio
1.71
Quick Ratio
1.71
Forward P/E
29.08
Price / Sales
1.06
Enterprise Value
$3.92 B
EV / EBITDA
84.91
EV / Revenue
0.99
Rating
Strong Buy
Target Price
$25.5
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Centene Corporation | $39.26 | — | $19.34 B | — | -0.78% | -28.68% | $64.15 / $25.08 | $40.58 |
| 2. | Oscar Health, Inc. | $16.44 | — | $4.9 B | — | — | -44.35% | $23.8 / $10.69 | $3.29 |
| 3. | Molina Healthcare, Inc. | $153.28 | 17.21 | $8.02 B | — | 9.53% | 11.02% | $333.22 / $121.06 | $79.78 |
| 4. | Humana Inc. | $216 | 21.97 | $26.04 B | 1.68% | — | 7.04% | $315.35 / $163.11 | $146.42 |
| 5. | UnitedHealth Group Incorporated | $354.97 | 26.8 | $323.02 B | 2.73% | 9.74% | 12.54% | $489.79 / $234.6 | $103.87 |
| 6. | CVS Health Corporation | $77.63 | 55.78 | $99.22 B | 3.47% | 6.3% | 2.29% | $85.15 / $58.35 | $59.18 |
| 7. | The Cigna Group | $279.79 | 12.61 | $73.76 B | 2.24% | — | 15.13% | $350 / $239.51 | $158.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.01 B | 993.7 M | 1.02 B | 926.93 M | 701.24 M | — |
| Operating Profit | -10.28 M | 7.68 M | 22.75 M | -5.39 M | -22.55 M | — |
| Net Profit | -11.01 M | 3.73 M | 15.67 M | -9.11 M | -31.09 M | — |
| EPS in Rs | -0.05 | 0.02 | 0.08 | -0.04 | -0.15 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.95 B | 2.7 B | 1.82 B | 1.43 B |
| Operating Profit | 14.75 M | -101.56 M | -127.82 M | -128.64 M |
| Net Profit | -0.72 M | -128.03 M | -148.02 M | -149.55 M |
| EPS in Rs | -0 | -0.63 | -0.72 | -0.73 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.07 B | 782.06 M | 591.88 M | 633.86 M |
| Total Liabilities | 886.51 M | 681.11 M | 433.81 M | 394.56 M |
| Equity | 179.28 M | 99.85 M | 156.95 M | 238.13 M |
| Current Assets | 951.58 M | 661.64 M | 483.54 M | 544.55 M |
| Current Liabilities | 556.87 M | 351.85 M | 263.02 M | 229.96 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 139.93 M | 34.77 M | -59.19 M | -45.43 M |
| Investing CF | -14.97 M | 39.19 M | -147.26 M | -28.22 M |
| Financing CF | 18.04 M | 156.03 M | 0.1 M | 16.59 M |
| Free CF | 113.15 M | -6.65 M | -95.18 M | -69.2 M |
| Capex | -26.78 M | -41.42 M | -35.99 M | -23.77 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 48.25% | 27.16% | — | — |
| Earnings Growth % | 13.5% | 1.02% | — | — |
| Profit Margin % | -4.74% | -8.12% | -10.43% | — |
| Operating Margin % | -3.76% | -7.01% | -8.97% | — |
| Gross Margin % | 10.97% | 11.02% | 12.85% | — |
| EBITDA Margin % | -2.86% | -5.77% | -7.92% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.